Lubomir Bodnar
Siedlce, MZ, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
ddMVAC versus gemcitabine-cisplatin as neoadjuvant treatment for muscle-invasive urothelial bladder cancer: a multicenter real-world study.
Journal: Scientific reports
Published: April 26, 2026
PARP Inhibitors and the Risk of Serum Creatinine Elevation in Ovarian Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Journal: Cancers
Published: March 08, 2026
Real-World Outcomes of Primary Versus Interval Debulking Surgery in a Multicenter Cohort of Advanced Ovarian Cancer Patients Treated with Bevacizumab.
Journal: Cancers
Published: January 19, 2026
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial.
Journal: Lancet (London, England)
Published: August 29, 2025
Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models.
Journal: Science translational medicine
Published: June 18, 2025
Selective inhibition of aminopeptidase N by paclitaxel: Insights into enzymatic interactions with cytostatics and analgesics in cancers.
Journal: International journal of biological macromolecules
Published: June 09, 2025
Primary Invasive Vaginal Carcinoma Associated with Complete Utero-Vaginal Prolapse: A Case Report and Literature Review.
Journal: Journal of clinical medicine
Published: May 29, 2025
Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancer.
Journal: The oncologist
Published: April 29, 2025
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: April 16, 2025
Updated Guidelines for the Diagnosis and Treatment of Endometrial Carcinoma: The Polish Society of Gynecological Oncology (2025v).
Journal: Current oncology (Toronto, Ont.)
Published: April 14, 2025
Hypoxia alters the response of ovarian cancer cells to the mitomycin C drug.
Journal: Frontiers in cell and developmental biology
Published: February 11, 2025
Predictive and Prognostic Role of Systemic Immune-Inflammation Index (SII) in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil.
Journal: Biomedicines
Published: August 04, 2024
Last Updated: 09/26/2026